CDH2 and squamous cell carcinoma: Especially, the frequencies of hypervascular tumours in N-cadherin-expressing tumours were likely to be higher than that in N-cadherin-negative tumours, among squamous cell carcinoma (50.0 vs 30.0%), and among large cell carcinoma (60.0 vs 44.4%).